Hyperbolic tapering of antidepressants

Medically reviewed by: Ruben de Groot, doctor Last reviewed:

Hyperbolic tapering is an approach in which the absolute dose reductions generally become smaller as the dose gets lower.

The goal is not to make every taper long. It is to make reductions more proportionate when the lower end of the dose range becomes harder to tolerate.

Why make smaller reductions at lower doses?

The relationship between dose and pharmacological effect is not always linear. A reduction of a few milligrams at a high dose may therefore be different from the same absolute reduction close to zero.

Dutch multidisciplinary guidance includes progressively smaller doses for people who have risk factors for antidepressant withdrawal symptoms.

Does everyone need a hyperbolic taper?

No.

People without significant risk factors can often taper using standard marketed strengths. A complex schedule should not be treated as inherently superior.

A slower or hyperbolic approach may be considered when: - previous reductions caused clear withdrawal symptoms; - missed doses caused symptoms; - standard reductions repeatedly proved too large; - the final part of a taper has been particularly difficult.

Is “10% per month” a universal rule?

No. A fixed percentage and fixed interval cannot account for every medication or every patient.

Some people can reduce substantially faster. Others may need smaller reductions or more time. The clinically relevant principle is to adjust the plan to response rather than force every patient through the same timetable.

Formulations

At very low doses, standard tablets may not provide the required precision. Depending on the drug, liquid formulations, lower strengths or pharmacy preparations may be options.

Sources